U.S. Markets close in 2 hrs 53 mins

Michael Flynn pleads guilty to lying to the FBI and plans to 'cooperate' with Russia probe

Hunter Walker
White House Correspondent

WASHINGTON — President Trump’s former national security adviser, Michael Flynn, pleaded guilty on Friday morning to a charge of making false statements to the FBI. Flynn also indicated he plans to cooperate with special counsel Robert Mueller’s investigation into alleged Russian interference in the 2016 U.S. presidential election. Mueller filed the charges against Flynn on Thursday in a three-paragraph “information” that leaves many questions about Flynn’s activities unanswered.

Flynn, a retired general, could face up to five years in prison. He is the fourth figure from Trump’s presidential campaign to face charges, and there are indications that he may be cooperating with prosecutors in the broader Russia probe.

In a statement released by his attorney’s office shortly after he made the plea, Flynn claimed he has faced “false accusations” of “treason.” However, he also acknowledged that the actions he pleaded guilty to were “wrong” and indicated that his guilty plea was part of an “agreement to cooperate with the Special Counsel’s Office.”

“After over 33 years of military service to our country, including nearly five years in combat away from my family, and then my decision to continue to serve the United States, it has been extraordinarily painful to endure these many months of false accusations of ‘treason’ and other outrageous acts. Such false accusations are contrary to everything I have ever done and stood for. But I recognize that the actions I acknowledged in court today were wrong, and, through my faith in God, I am working to set things right,” said Flynn.

Former Trump national security adviser Michael Flynn, center, arrives at federal court in Washington, D.C., on Dec. 1.  (Photo: Susan Walsh/AP)

Flynn described his decision to cooperate with prosecutors as one that was made “in the best interests of my family and of our country.”

“I accept full responsibility for my actions,” he said.

A Flynn confidant said the retired general promised “full cooperation” in the probe, ABC News reported, and that he is prepared to testify that Trump asked him to make contact with the Russians.

The law firm indicated Flynn and his attorney, Robert Kelner, would not make further public statements about the plea.

Flynn, a retired general, was accused of making a pair of false statements about conversations he had with Russia’s ambassador to the United States during the transition period before the inauguration. A top adviser to Trump’s campaign, Flynn was appointed national security adviser days after Trump’s election in November 2016. According to the criminal information filed by Mueller and his assistants in the U.S. District Court for the District of Columbia, Flynn’s conversations with the Russian ambassador, Sergey Kislyak, took place the following month, as he worked with Trump’s transition team.

The information said Flynn spoke to FBI agents on Jan. 24, 2017, four days after Trump took office and he officially became national security adviser. During that interview, Flynn allegedly lied about discussions he had with Kislyak about U.S. sanctions on Russia and a U.N. Security Council resolution.

According to the document, Flynn spoke to Kislyak on Dec. 29, the day the outgoing Obama administration issued sanctions to respond to Russia’s alleged intervention in the election. Mueller and his team said Flynn falsely said he “did not ask” Kislyak to “refrain from escalating the situation.” Mueller and his team also said Flynn spoke to Kislyak last Dec. 22. Flynn allegedly falsely told FBI agents that he did not ask the Russian ambassador to “delay the vote on or defeat a pending United Nations Security Council resolution.”

Sergey Kislyak, Russia’s ambassador to the United States, visits the State Department in Washington, D.C., in July. (Photo: Carolyn Kaster/AP)

The charging documents were made public on Friday morning. Shortly afterwards, the White House referred questions about the charges to Ty Cobb, the lawyer who is handling for the Trump administration issues related to the Russia investigation. The White House subsequently released a statement from Cobb in which he emphasized the fact that Flynn spent a little over three weeks in the Trump administration before being fired from his post as national security adviser, after it was revealed that he misled Vice President Mike Pence about his conversations with Kislyak.

“Today, Michael Flynn, a former national security adviser at the White House for 25 days during the Trump administration, and a former Obama administration official, entered a guilty plea to a single count of making a false statement to the FBI,” Cobb said, adding, “The false statements involved mirror the false statements to White House officials which resulted in his resignation in February of this year. Nothing about the guilty plea or the charge implicates anyone other than Mr. Flynn. The conclusion of this phase of the Special Counsel’s work demonstrates again that the Special Counsel is moving with all deliberate speed and clears the way for a prompt and reasonable conclusion.”

Flynn has been the subject of intense scrutiny for months. In addition to the concerns about his communications with Kislyak, Flynn has faced questions about whether he failed to declare lobbying work he did for the Turkish government and whether he worked with Istanbul on a plot to hand over a Turkish dissident who is living in the United States. Flynn’s meeting with Turkish representatives allegedly took place last December during the presidential transition and involved his son, Michael Flynn Jr. Flynn’s son was also implicated in the payments from the Turkish government, since he worked in his father’s consulting business.

Michael Flynn (right) and his son Michael G. Flynn, left, at Trump Tower in New York in November 2016 (Photo: Carolyn Kaster/AP)

Legal experts have speculated that the potential for charges against Flynn’s son could give prosecutors leverage against him. Flynn was spared the more serious charges he could have faced for failing to register his work with Turkey or for negotiating with the Russian ambassador while he was still a private citizen.

The deal between Flynn and prosecutors is a major development as the Russia probe heats up and has ensnared several Trump allies. Last month, Trump’s former campaign chairman, Paul Manafort, was indicted along with a longtime associate on charges including making false statements to investigators and acting as unregistered foreign agents on behalf of Viktor Yanukovych, the former president of the Ukraine, who was closely allied with the Kremlin. A lower-level former campaign aide, George Papadopoulos, was also charged with making false statements to the FBI about his outreach to Russia during the presidential campaign. Papadopoulos has pleaded guilty.

In a report released in January, the U.S. intelligence community said the Russian government had interfered in last year’s presidential election to help Trump against his rival, Democrat Hillary Clinton. Trump and his administration have repeatedly denied that he had any involvement with Russia’s efforts. The White House has also sought to distance Trump from the former aides who have faced criminal charges.

Michael Flynn, with a detail of a U.S. District Court document (Yahoo News photo illustration; photos: Mario Tama/Getty Images)

This story was updated at 11:55 a.m. with the statements from Flynn and Cobb.

Read more from Yahoo News:

  • Why Tesla Stock Jumped Tuesday
    Motley Fool

    Why Tesla Stock Jumped Tuesday

    Shares of electric-car company Tesla (NASDAQ: TSLA) popped on Tuesday, rising as much as 7.5%. The stock's rise comes after the electric-car company scheduled its earnings report about a week earlier than usual with just two days' notice, leading to some speculation that the automaker may have achieved its goal to become profitable during the quarter. Citron Research, which had previously encouraged investors to short Tesla stock, is now reversing its stance on the stock.

  • Business

    Stocks to Buy, Stocks to Dump in This Volatile Market

    Get Some Much will be made of this morning's equity market selloff. There will be calls made on both sides. Bulls will state their case. Bears will make theirs. Financial TV will be full of them, and a lot of them, you and I know will be full of

  • Suze Orman missed the point of retirement, and that’s why she went back to work

    Suze Orman missed the point of retirement, and that’s why she went back to work

    Suze Orman did a smackdown of the FIRE (Financial Independence/Retire Early) movement on Paula Pant’s podcast. Coach Carson posted a balanced, informative response, appreciating Suze’s admonition to be sure you have enough for a risk-free retirement. Suze enumerated a string “what can go wrong” scenarios as evidence that early retirement (on less than $10 million) leaves you vulnerable when life hands you lemons — a whole tree of lemons.

  • 5 Deeply Discounted Value Stocks That Haven't Been This Cheap in at Least a Decade
    Motley Fool

    5 Deeply Discounted Value Stocks That Haven't Been This Cheap in at Least a Decade

    October has been a wake-up call for investors that the stock market won't go up in a straight line, even if we'd like it to. Sure, Bank of America (NYSE: BAC) has seen its stock catapult higher from its Great Recession lows, but its forward P/E of 9.8 would represent a more-than-decade low for the stock.

  • The stock market's 'dead cat bounce' is over and the rolling bear market is making a comeback, Morgan Stanley says
    Business Insider

    The stock market's 'dead cat bounce' is over and the rolling bear market is making a comeback, Morgan Stanley says

    The stock market may have bounced back from its sharp sell-off at the beginning of October, but Morgan Stanley says the selling will pick back up soon. The firm expects the S&P 500 to slide back below the 200-day moving average, a key technical level. Tread carefully in tech and consumer discretionary, Morgan Stanley warns.

  • Why Nektar Therapeutics Crashed 17.2% Today
    Motley Fool

    Why Nektar Therapeutics Crashed 17.2% Today

    After delivering a disappointing update on NKTR-214 in cancer patients this summer, Nektar Therapeutics' (NASDAQ: NKTR) shares have been struggling. The company didn't report any news today, so a negative report issued by Plainview LLC this month may be to blamed for its 17.2% tumble today. In February, Bristol-Myers Squibb (NYSE: BMY) inked a blockbuster deal to license rights to NKTR-214 following positive data last year for NKTR-214's use alongside Bristol-Myers' Opdivo.

  • These stocks may be sacrificed in a cold war with China
    CNBC Videos

    These stocks may be sacrificed in a cold war with China

    Jim Cramer says the escalation in the United States' trade war with China could end in an outright cold war that debilitates parts of the stock market.

  • Finance

    Here's the tax bite on $1.6 billion Mega Millions and $620 million Powerball jackpots

    Strategies can be employed to reduce the amount of your win that is taxed, although they are best explored with the help of an experienced tax advisor. While it's anyone's guess who will end up winning the Mega Millions and Powerball jackpots, there's at least one guaranteed recipient of a chunk of the loot — the IRS. With the Mega Millions jackpot at $1.6 billion and Powerball's top prize at $620 million, that tax bill will be hefty even if the winner employs strategies to reduce their taxable income.

  • 4 Things Aurora Cannabis Did Right Before Its NYSE Debut
    Motley Fool

    4 Things Aurora Cannabis Did Right Before Its NYSE Debut

    Aurora Cannabis (NASDAQOTH: ACBFF) (TSX: ACB) has sought to make it even easier for U.S. investors to buy its shares by arranging to have its shares listed on the New York Stock Exchange. Beginning tomorrow, Oct. 23, Aurora will join the elite group of cannabis companies whose shares trade on major U.S. exchanges. Getting ready for the increased exposure that a NYSE listing brings takes time and effort, and Aurora Cannabis hasn't wasted any time.

  • Is the New Energy Transfer LP a Buy?
    Motley Fool

    Is the New Energy Transfer LP a Buy?

    Last week, Energy Transfer LP (NYSE: ET) emerged on the scene after the former Energy Transfer Equity completed the acquisition of its affiliate Energy Transfer Partners in a unit-for-unit exchange that simplified this complex midstream franchise. The transaction also created a much stronger company that has the financial resources to fund a significant slate of expansion projects. The new Energy Transfer is a behemoth in the midstream sector.

  • Stocks plunge, Dow drops more than 400 points
    Yahoo Finance

    Stocks plunge, Dow drops more than 400 points

    US equities took a nosedive Tuesday, extending a rout in global stocks. The Dow (^DJI) slid 1.77%, or 448.1 points, as of 11:46 a.m. ET, as major manufacturers Caterpillar and 3M posted disappointing financial results. The S&P 500 (^GSPC) fell 1.74%,

  • Verizon beats Wall Street estimates, shares hit 18-year high

    Verizon beats Wall Street estimates, shares hit 18-year high

    The largest U.S. wireless carrier by subscribers has been focusing on upgrading its network and winning over more customers in a saturated market as rivals AT&T Inc , Sprint Corp and T-Mobile have been focusing on merger deals and paying down debt. Verizon shares rose 3.4 percent to $56.87, their highest in more than 18 years. The company said it added a net 295,000 phone subscribers who pay a monthly bill during the third quarter, easily beating the estimate of 161,000 provided by research firm FactSet.

  • Business
    Motley Fool

    Parsing Visa's Big Quarterly Dividend Hike

    The ubiquitous financial services player Visa (NYSE: V) isn't exactly an income stock -- its dividend yield has fairly consistently been below 1% for years. Which raises two interesting questions for MarketFoolery host Chris Hill and senior analyst Jason Moser. In this segment from MarketFoolery, they discuss Visa's cash cow structure, its stock repurchases, and the M&A possibilities it thus far seems to be ignoring.

  • Why Pot Stocks Canopy Growth, Cronos Group, and Tilray Are Cratering Today
    Motley Fool

    Why Pot Stocks Canopy Growth, Cronos Group, and Tilray Are Cratering Today

    Canadian pot stocks are getting hit hard across the board today. As of 1:21 p.m. EDT, for example, shares of Canopy Growth Corporation (NYSE: CGC) and Cronos Group (NASDAQ: CRON) were both down by 11.2%, whereas Tilray's(NASDAQ: TLRY) stock had fallen by 14.4%. Canopy, Cronos, and Tilray all seem to be succumbing to a so-called "sell the news" event.

  • Former General Electric vice chair on the company's futur...
    CNBC Videos

    Former General Electric vice chair on the company's futur...

    Beth Comstock, Nike board member and former vice chair of General Electric, weighs in on the future of General Electric under new CEO Larry Culp.

  • News

    Here's how much money you should have saved by 50

    Fidelity, the nation's largest retirement-plan provider, recommends having the equivalent of six times your annual salary saved. To get to that number, Fidelity recommends saving 15 percent of your annual income. Make sure to invest these funds instead of leaving them in a traditional low-interest savings account.

  • Exploring Symantec’s Latest
    Market Realist

    Exploring Symantec’s Latest

    Symantec’s (SYMC) revenue fell at a four-year CAGR (compound annual growth rate) of 7% to $5 billion in fiscal 2018, which ended on March 31, 2018. Symantec’s revenues are expected to be $4.7 billion, $5 billion, and $5.1 billion, respectively, in fiscal 2019, fiscal 2020, and fiscal 2021. At the end of last week, SYMC had underperformed the NASDAQ Composite Index and the S&P 500 Systems Software Index in the last three months, in the last year, and year-to-date.

  • Business

    Lender Fifth Third sees interest income rising; shares buck downtrend

    * Q4 net interest income expected to rise vs Q3 * Shares up 1.2 pct in a broadly lower market * Q3 adjusted EPS beat Refinitiv estimates (Adds outlook, shares) Oct 23 (Reuters) - Fifth Third Bancorp said on

  • Trump’s Tax Push to Help Middle Class Could Help Top Earners Too

    Trump’s Tax Push to Help Middle Class Could Help Top Earners Too

    It’s still unclear how Trump will propose to reduce the tax burden on middle-class Americans, but one of the most straightforward ways would be to lower rates by 10 percent for single filers making up to $82,500. U.S. income tax rates are graduated and income dollars get taxed in chunks as they move up through the brackets -- which means wealthy Americans would also get to apply the reduced rate on their first dollars of income. “A millionaire gets the same size tax cut,” said Kyle Pomerleau, an economist at the conservative Tax Foundation.

  • Why Investors Are Paying a Premium for These 3 Biotech Stocks
    Motley Fool

    Why Investors Are Paying a Premium for These 3 Biotech Stocks

    Amarin stock exploded in September because it looks like Vascepa will become the next go-to drug for this enormous population. During the 8,179-patient Reduce-It trial, patients given Vascepa in addition to their normal statin treatments were 25% less likely to suffer a major cardiovascular event such as a heart attack. Over the past year, Amarin Corporation actually lost $92 million because sales of Vascepa just haven't kept pace with operating expenses.

  • Dow tumbles nearly 550 points at lows amid corporate outlook, China selloff

    Dow tumbles nearly 550 points at lows amid corporate outlook, China selloff

    It was a punishing start for stocks Tuesday as investors reacted negatively to quarterly results from a handful of blue chips and the cessation of a two-day rebound for China’s embattled stock market, reviving fresh questions about global economic growth prospects. The Dow Jones Industrial Average (DJIA) 548.62 points at its low and remained was recently 460 points, or 1.8%, at 24,862. The S&P 500 (SPX) fell 55 points, or 2%, to 2,696, retreating below a psychological and technical mark at 2,700, while the Nasdaq Composite Index (COMP) slid gave up 177 points, or 2.4%, to 7,291.

  • Are AMD Investors Overreacting to Intel’s CPU Supply Update?
    Market Realist

    Are AMD Investors Overreacting to Intel’s CPU Supply Update?

    Are AMD Investors Overreacting to Intel’s News? (Continued from Prior Part) The 2018 CPU story of AMD and Intel The Advanced Micro Devices-Intel CPU (central processing unit) story is taking an interesting twist in 2018 as Intel faces CPU supply shortage

  • What the Market Missed in Kinder Morgan Inc.'s Results
    Motley Fool

    What the Market Missed in Kinder Morgan Inc.'s Results

    Kinder Morgan (NYSE: KMI) can't seem to catch a break these days. Despite its completing what management dubbed a "momentous" quarter, shares of the natural gas pipeline giant barely budged this week. It was a head-scratching outcome considering that its financial results came in well above its guidance, which the market seems to have completely missed.

  • Weed stocks are tanking as Aurora Cannabis debuts on the New York Stock Exchange (TLRY, CRON, CGC)
    Business Insider

    Weed stocks are tanking as Aurora Cannabis debuts on the New York Stock Exchange (TLRY, CRON, CGC)

    Aurora Cannabis made its trading debut on the New York Stock Exchange. Weed stocks are getting slammed across the board, trading down between 7% and 14% before paring their losses. Weed stocks were under pressure Tuesday morning as one of the largest cannabis producers, Aurora Cannabis, debuted for trading on the New York Stock Exchange.

  • What to Expect from Bristol-Myers Squibb’s Q3 Earnings
    Market Realist

    What to Expect from Bristol-Myers Squibb’s Q3 Earnings

    Bristol-Myers Squibb (BMY) is expected to report its third-quarter earnings on October 25. Analysts expect Bristol-Myers Squibb’s revenues to increase 8.87% from $5.25 billion in the third quarter of 2017 to $5.72 billion in the third quarte of 2018. In the last four quarters, Bristol-Myers Squibb’s revenue growth has been 3.93%–10.89%.